VRVg-2 + Purified Inactivated Rabies Vaccine + Human Diploid Cell Vaccine (HDCV) + Rabies immune globulin (human)
Phase 3Completed 0 watching 0 views this week📈 Rising
76
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Rabies (Healthy Volunteers)
Conditions
Rabies (Healthy Volunteers)
Trial Timeline
Jul 1, 2019 → Jul 1, 2021
NCT ID
NCT03965962About VRVg-2 + Purified Inactivated Rabies Vaccine + Human Diploid Cell Vaccine (HDCV) + Rabies immune globulin (human)
VRVg-2 + Purified Inactivated Rabies Vaccine + Human Diploid Cell Vaccine (HDCV) + Rabies immune globulin (human) is a phase 3 stage product being developed by Sanofi for Rabies (Healthy Volunteers). The current trial status is completed. This product is registered under clinical trial identifier NCT03965962. Target conditions include Rabies (Healthy Volunteers).
Hype Score Breakdown
Clinical
27
Activity
18
Company
9
Novelty
9
Community
10
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT03965962 | Phase 3 | Completed |
Competing Products
20 competing products in Rabies (Healthy Volunteers)